← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Adynxx, Inc.
San Francisco, CA
$6,319,604
Total funding
2
Grants
Funding over time
peak $3.5M · FY2019–20$5M$3.8M$2.5M$1.3M$0
'19
'20
Funding mix
By agency
NIH$6,319,604 · 2
By mechanism
UG3$5,717,088 · 1
R43$602,516 · 1
Investigators at Adynxx, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
The long-term reduction of pain and opioid usage following mastectomy and tissue expander/implant surgery with a single administration of brivoligide, a non-opioid, disease-modifying drug candidate$2,858,544
UG3 · FY2020 · DA
The long-term reduction of pain and opioid usage following mastectomy and tissue expander/implant surgery with a single administration of brivoligide, a non-opioid, disease-modifying drug candidate$2,858,544
UG3 · FY2019 · DA
Pharmacokinetic and toxicology studies of AYX2, a transcription factor decoy, non-opioid, disease modifying drug candidate for the long-term treatment of chronic pain$602,516
R43 · FY2019 · NS